VIVUS, INC.
Patent Owner
Stats
- 43 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Aug 08, 2017 most recent publication
Details
- 43 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,084 Total Citation Count
- Oct 30, 1991 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0151,179 Low Dose Topiramate/Phentermine Composition and Methods of Use ThereofJul 06, 16Jun 01, 17[A61K]
2017/0119,730 Combination Therapy for Effecting Weight Loss and Treating ObesityJun 03, 16May 04, 17[A61K]
2016/0250,180 ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITYMay 10, 16Sep 01, 16[A61K]
2016/0045,527 TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONISTAug 13, 15Feb 18, 16[A61K]
2016/0015,730 Treatment of Pulmonary Hypertension with Carbonic Anhydrase InhibitorsJul 22, 15Jan 21, 16[A61K]
2015/0379,328 NETWORK-BASED PATHOLOGY SYSTEM WITH DESKTOP SLIDE SCANNERSep 08, 15Dec 31, 15[H04N, G06F, G02B, G06K]
2015/0328,246 ORALLY ADMINISTRATABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENTMay 15, 15Nov 19, 15[A61K, B29C]
2014/0294,950 METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONSMar 17, 14Oct 02, 14[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9011905 Low dose topiramate/phentermine composition and methods of use thereofSep 24, 14Apr 21, 15[A61K]
9011906 Escalating dosing regimen for effecting weight loss and treating obesitySep 24, 14Apr 21, 15[A61K]
8895057 Escalating dosing regimen for effecting weight loss and treating obesityOct 08, 13Nov 25, 14[A61K]
8895058 Low dose topiramate/phentermine composition and methods of use thereofOct 08, 13Nov 25, 14[A61K]
8580298 Low dose topiramate/phentermine composition and methods of use thereofJun 09, 09Nov 12, 13[A61K]
8580299 Escalating dosing regimen for effecting weight loss and treating obesityJun 09, 09Nov 12, 13[A61K]
8536138 Treatment of pulmonary hypertension with carbonic anhydrase inhibitorsDec 05, 11Sep 17, 13[A61K, A61P]
8071557 Treatment of pulmonary hypertension with carbonic anhydrase inhibitorsJun 13, 07Dec 06, 11[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0310,446 Low Dose Topiramate/Phentermine Composition and Methods of Use ThereofAbandonedDec 15, 15Oct 27, 16[A61K]
2016/0022,630 ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITYAbandonedOct 08, 15Jan 28, 16[A61K]
2015/0313,870 LOW DOSE TOPIRAMATE / PHENTERMINE COMPOSITION AND METHODS OF USE THEREOFAbandonedApr 06, 15Nov 05, 15[A61K]
2015/0231,110 TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENTAbandonedMay 06, 15Aug 20, 15[A61K]
2015/0209,325 Escalating Dosing Regimen for Effecting Weight Loss and Treating ObesityAbandonedApr 06, 15Jul 30, 15[A61K]
2015/0025,134 Compositions and Methods for the Treatment of Sleep ApneaAbandonedOct 09, 14Jan 22, 15[A61K]
2014/0308,346 COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITYAbandonedJun 27, 14Oct 16, 14[A61K]
2014/0288,944 METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKSAbandonedMar 14, 14Sep 25, 14[G09B, G06F]
2014/0094,511 Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active AgentAbandonedOct 17, 13Apr 03, 14[A61K]
2014/0088,162 Treatment of Pulmonary Hypertension with Carbonic Anhydrase InhibitorsAbandonedSep 12, 13Mar 27, 14[A61K]
2011/0262,535 Low Dose Topiramate / Phentermine Composition and Methods of Use ThereofAbandonedJul 01, 11Oct 27, 11[A61K, A61P]
2011/0224,196 TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENTAbandonedJan 07, 11Sep 15, 11[A61K, A61P]
2010/0087,402 Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disordersAbandonedSep 29, 09Apr 08, 10[A61K]
2009/0304,789 NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERSAbandonedJun 09, 08Dec 10, 09[A61K, A61P]
2008/0255,093 COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERSAbandonedApr 29, 08Oct 16, 08[A61K, A61P]
2008/0227,749 CARRAGEENAN-BASED FORMULATIONS AND ASSOCIATED METHODS OF USEAbandonedMar 31, 08Sep 18, 08[A61K, A61P]
2005/0239,742 Carrageenan-based formulations and associated methods of useAbandonedApr 07, 05Oct 27, 05[A61K]
2005/0070,516 As-needed administration of an androgenic agent to enhance female desire and responsivenessAbandonedNov 16, 04Mar 31, 05[A61K]
2004/0044,080 Treatment of dyspareunia with topically administered nitroglycerin formulationsAbandonedApr 04, 03Mar 04, 04[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
